Purchase Order 75F40118P10255
Award Date 8/20/18
Potential Completion Date 11/30/19
Potential Value $130K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lancaster, CA 93534, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Simulations Plus Inc., a for-profit software company specializing in pharmaceutical modeling and simulation. The contract, valued at $109,798.77, is for the purchase of 50 GastroPlus licenses, 30 IVIVCPlus module licenses, and 30 PBPK Plus licenses. The contract has no set-aside designation and is not associated with a larger contract vehicle. Simulations Plus has previously provided similar software...
- This is a $375,965.05 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for GastroPlus, DDDPlus, and MembraneePlus software licenses. The contract has an ultimate completion date of August 31, 2026 and does not have a set-aside designation. Simulations Plus is a for-profit company that specializes in developing pharmaceutical modeling and simulation software, including tools for physiologically-based pharmacokinetic (PBPK) modeling, drug...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Simulations Plus Inc. for an annual software license for one user to access the company's ADMET and GastroPlus modeling and simulation software. The total ceiling value of the contract is $96,898.01 and the ultimate completion date is January 31, 2026. The software provided under this award supports pharmaceutical drug research, development, and regulatory assessment through...
- This is a $1,844,289.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research. The contract is for advancing in vitro and (patho)physiology-based pharmacokinetics models to understand and predict pulmonary absorption and tissue retention of inhaled drugs. The contract has no set-aside designation. As a subcontractor, Simulations Plus Inc. will provide modeling and simulation services to support the...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for the renewal of ADMET Predictor software licenses and associated support services. The contract, valued at $100,337.38, has an ultimate completion date of February 19, 2026. The original solicitation sought to renew the FDA's existing licenses for the ADMET Predictor software, which is used by the Center for Tobacco Products (CTP) for toxicology data mining and assessing the...
- This is a firm-fixed-price purchase order contract awarded by the Environmental Protection Agency's Office of Research and Development to Simulations Plus Inc. for a software license for the ADMET Predictor and GastroPlus modules. The contract has a ceiling value of $55,763.60 and a period of performance ending on May 21, 2027. The contract is not set aside for any specific socioeconomic category. The contract was awarded as a sole-source procurement, as the agency indicated its intent to...
- The U.S. Food and Drug Administration (FDA) awarded a $144,000.00 firm-fixed-price purchase order contract to Certara UK LIMITED, doing business as Certara, for the purchase of SIMCYP software. SIMCYP is a physiologically-based pharmacokinetic (PBPK) modeling software used to simulate drug absorption, distribution, metabolism, and excretion processes, which is crucial for optimizing drug development and facilitating regulatory reviews. This contract is not set aside for any specific business...
- The University of Health Sciences and Pharmacy in St. Louis was awarded a $1.16 million cost-no-fee definitive contract by the Department of Health and Human Services' Food and Drug Administration to develop an in vitro/in silico model to accelerate generic drug product development for the oral cavity route of administration. This contract was awarded under the FDA's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to support...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Certara USA Inc., a leading provider of biosimulation software and consulting services. The contract, valued at $16,441.10, is for the procurement of software licenses for Certara's proprietary modeling and simulation tools, including Phoenix WinNonlin, Certara Phoenix, CHEMOFFICE, and SEND EXPLORER. These software products enable federal scientists and reviewers to conduct...
- The Food and Drug Administration awarded a $107,856.04 firm fixed-price purchase order to Anylogic North America, LLC for AnyLogic software licenses and maintenance services. The contract, awarded on August 10, 2022, with an ultimate completion date of August 16, 2027, supports the FDA's computational modeling and simulation capabilities. The award was made without a set-aside designation to this Villa Park, Illinois-based vendor, which specializes in providing simulation modeling software and...